LINDSAY JEWELL: Open Payments
NPI 1770891988 · JACKSONVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,762 in 87 payments from 22 companies in 2025. Trend: 2023 $397 · 2024 $1,880 · 2025 $1,762
Food & beverage: $1,762
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 14 | $388 |
| ABBVIE INC. | 22 | $310 |
| Axsome Therapeutics, Inc. | 5 | $153 |
| PFIZER INC. | 5 | $107 |
| E.R. Squibb & Sons, L.L.C. | 5 | $102 |
| Lundbeck LLC | 4 | $84 |
| Otsuka America Pharmaceutical, Inc. | 4 | $79 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $59 |
| Lilly USA, LLC | 3 | $50 |
| Amgen Inc. | 3 | $49 |
Products named: AIRSUPRA, VRAYLAR, REXULTI, Auvelity, UBRELVY, PREVNAR 20, CAMZYOS, BREZTRI.
Industry payments across FL — which companies pay providers there.
